APPLICATION
ANDA065265
TYPE
ANDA
ORIGINAL APPROVAL
2007-01-18
LATEST ACTION
2016-10-07
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
AZITHROMYCINDiscontinued
AZITHROMYCIN EQ 500MG BASE/VIAL · INJECTABLE · INJECTION
Approval history
2016-10-07Labeling · Supplement 4 · standardAP
2013-01-03Labeling · Supplement 3AP
2007-01-18OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.